TY - JOUR
T1 - Endogenous and exogenous opioids in pain
AU - Corder, Gregory
AU - Castro, Daniel C.
AU - Bruchas, Michael R.
AU - Scherrer, Grégory
N1 - Funding Information:
We apologize to all investigators whose work could not be appropriately cited owing to space and citation limitations of this journal. This work was supported by National Institutes of Health grants R01DA044481 (G.S.), R01DA033396 (M.R.B), K99DA043609 (G.C.), and F32DA043999 (D.C.C). G.S. is a New York Stem Cell Foundation – Robertson Investigator. We thank Dr. Aashish Manglik for providing images of opioid receptor crystal structures (Figure 1).
Publisher Copyright:
© 2018 by Annual Reviews. All rights reserved.
PY - 2018/7/8
Y1 - 2018/7/8
N2 - Opioids are the most commonly used and effective analgesic treatments for severe pain, but they have recently come under scrutiny owing to epidemic levels of abuse and overdose. These compounds act on the endogenous opioid system, which comprises four G protein-coupled receptors (mu, delta, kappa, and nociceptin) and four major peptide families (β-endorphin, enkephalins, dynorphins, and nociceptin/orphanin FQ). In this review, we first describe the functional organization and pharmacology of the endogenous opioid system. We then summarize current knowledge on the signaling mechanisms by which opioids regulate neuronal function and neurotransmission. Finally, we discuss the loci of opioid analgesic action along peripheral and central pain pathways, emphasizing the pain-relieving properties of opioids against the affective dimension of the pain experience.
AB - Opioids are the most commonly used and effective analgesic treatments for severe pain, but they have recently come under scrutiny owing to epidemic levels of abuse and overdose. These compounds act on the endogenous opioid system, which comprises four G protein-coupled receptors (mu, delta, kappa, and nociceptin) and four major peptide families (β-endorphin, enkephalins, dynorphins, and nociceptin/orphanin FQ). In this review, we first describe the functional organization and pharmacology of the endogenous opioid system. We then summarize current knowledge on the signaling mechanisms by which opioids regulate neuronal function and neurotransmission. Finally, we discuss the loci of opioid analgesic action along peripheral and central pain pathways, emphasizing the pain-relieving properties of opioids against the affective dimension of the pain experience.
KW - analgesia
KW - neuroanatomy
KW - opioid
KW - pain
KW - perception
KW - signaling
UR - http://www.scopus.com/inward/record.url?scp=85048460874&partnerID=8YFLogxK
U2 - 10.1146/annurev-neuro-080317-061522
DO - 10.1146/annurev-neuro-080317-061522
M3 - Review article
C2 - 29852083
AN - SCOPUS:85048460874
SN - 0147-006X
VL - 41
SP - 453
EP - 473
JO - Annual Review of Neuroscience
JF - Annual Review of Neuroscience
ER -